Ruane, Cunniff & Goldfarb’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Ruane, Cunniff & Goldfarb's NVO Position: Q2 2017 in Review
Ruane, Cunniff & Goldfarb sold out of Novo Nordisk (NVO) in Q2 2017, closing a stake of 77,540 shares — an estimated $1.33M sold.
Ruane, Cunniff & Goldfarb first reported a position in NVO in Q2 2013 and held it in 16 quarters. The position peaked at $11.5M in Q4 2013. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.
- Ruane, Cunniff & Goldfarb reported no remaining Novo Nordisk position as of Q2 2017 after selling out during the quarter.
- Ruane, Cunniff & Goldfarb sold 77,540 Novo Nordisk shares in Q2 2017, an estimated $1.33M.
- Ruane, Cunniff & Goldfarb first reported a position in Novo Nordisk in Q2 2013 and held it in 16 quarters.
- Ruane, Cunniff & Goldfarb's Novo Nordisk position peaked at $11.5M in Q4 2013.
- 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.
Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2017, filed 14 Aug 2017.